Torway Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.40 M
as on 16-11-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.40 Cr
as on 16-11-2024
- Revenue -4.56%
(FY 2023)
- Profit 136.60%
(FY 2023)
- Ebitda 2.74%
(FY 2023)
- Net Worth 22.15%
(FY 2023)
- Total Assets 35.32%
(FY 2023)
About Torway Pharmacia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹2.40 Cr.
Manish Goyal and Deepak Goyal serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC201600
- Company No.
201600
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Torway Pharmacia Private Limited offer?
Torway Pharmacia Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Torway Pharmacia?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Goyal  | Director | 15-Apr-2010 | Current |
| Deepak Goyal | Director | 15-Apr-2010 | Current |
Financial Performance of Torway Pharmacia.
Torway Pharmacia Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.56% decrease. The company also saw a substantial improvement in profitability, with a 136.6% increase in profit. The company's net worth Soared by an impressive increase of 22.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Torway Pharmacia?
In 2023, Torway Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2019 | ₹2.00 Cr | Open |
Syndicate Bank Creation Date: 19 Nov 2018 | ₹4.00 M | Open |
How Many Employees Work at Torway Pharmacia?
Torway Pharmacia has a workforce of 1 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Torway Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torway Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
